Skip to main content
. 2004 May;42(5):2085–2093. doi: 10.1128/JCM.42.5.2085-2093.2004

TABLE 3.

LightCycler quantification of C. albicans ERG11, CDR1, CDR2, and MDR1 mRNA

Isolate no. Susceptibility interpretationb Mean expression units ± SDa
ERG11c CDR1d CDR2d MDR1
1 R 3.98 ± 0.64 4.89 ± 0.86 1.21 ± 0.16 0
2 R 5.39 ± 0.56 4.33 ± 0.76 1.71 ± 0.29 0.20 ± 0.03
3 R 4.78 ± 0.63 8.35 ± 0.16 0.85 ± 0.09 0.63 ± 0.16
4 SDD 3.90 ± 0.45 5.16 ± 0.44 2.01 ± 0.28 0
5 SDD 2.35 ± 0.46 13.14 ± 1.43 1.01 ± 0.15 0.61 ± 0.14
6 SDD 3.97 ± 0.50 5.04 ± 0.60 2.82 ± 0.45 0
7 SDD 2.52 ± 0.40 2.42 ± 0.49 0.62 ± 0.04 156.50 ± 11.63
8 S 2.08 ± 0.32 2.43 ± 0.83 0.26 ± 0.05 0
9 S 1.87 ± 0.08 1.43 ± 0.22 0.30 ± 0.02 0
10 S 1.56 ± 0.27 2.06 ± 0.22 0.24 ± 0.05 0
a

Gene expression normalized to ACT1 expression for each isolate.

b

Fluconazole susceptibility category (R, resistant; SDD, susceptible dose dependent; S, susceptible).

c

Overexpression in R compared to S and SDD isolates and in SDD compared to S isolates (P ≤ 0.05).

d

Overexpression in R compared to S isolates (P ≤ 0.08).